The death of a Louisiana resident and a severe infection involving a B.C. teen has experts worried about the emerging threat ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna MRNA shares soared 11.7% in the last trading session to close at $47.53. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...